title: Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study.
abstract: Midlife cardiovascular risk, hypertension (HTN) in particular, has been related cross-sectionally to poorer neuropsychological (NP) performance in middle age and older adults. This study investigated whether a similar relationship persists between midlife HTN or systolic blood pressure (SBP) and NP performance approximately 30 years later. 378 Framingham stroke and dementia-free Original cohort participants, with HTN and SBP ascertained between 50-60 years of age (mean age 55 ± 1, 65% women), were administered a NP assessment at age ≥80 years. Tests included Logical Memory, Visual Reproduction, Paired Associate, Hooper Visual Organization Test, Trail Making A & B, Digit Span Forward and Backward, Controlled Word Association Test (COWAT), and Similarities. Multivariable linear regression, adjusted for age, time interval between risk factor and NP testing, gender, and premorbid intelligence, assessed association between midlife HTN/SBP and NP outcomes. Midlife HTN was not significantly associated with NP outcome measures. Midlife SBP was associated with poorer Digit Span Forward and COWAT performance (p <  0.05). No significant interaction of age on HTN/SBP to NP associations was found. There was a significant interaction between ApoE4 status and SBP in their effects on COWAT (pinteraction = 0.074); SBP was negatively associated with COWAT only in those with the ApoE4 allele (p = 0.025). While midlife HTN is not associated with late life cognitive impairment, midlife SBP is related to late life attention and verbal fluency impairments, particularly among ApoE4+ individuals. These results offer insight into processes that are operative in the absence of overt cognitive impairment and dementia.
authors.affiliation: Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Arvind
authors.initials: A
authors.lastname: Nishtala
authors.affiliation: Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Jayandra J
authors.initials: JJ
authors.lastname: Himali
authors.affiliation: Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA.|Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
authors.forename: Alexa
authors.initials: A
authors.lastname: Beiser
authors.affiliation: Framingham Heart Study, Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Joanne M
authors.initials: JM
authors.lastname: Murabito
authors.affiliation: Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Sudha
authors.initials: S
authors.lastname: Seshadri
authors.affiliation: Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Philip A
authors.initials: PA
authors.lastname: Wolf
authors.affiliation: Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Rhoda
authors.initials: R
authors.lastname: Au
mesh_terms: D000328:Adult; D000368:Aged; D001057:Apolipoproteins E / Q000235:genetics; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D003072:Cognition Disorders / Q000453:epidemiology*; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008404:Massachusetts / Q000453:epidemiology; D008875:Middle Aged; D009483:Neuropsychological Tests; D012307:Risk Factors
chemical_list: D001057:Apolipoproteins E